Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X)
J Segalla B. van Eyll; M Federico; M Perdicaris; S Cabral; N Skare; E saltz; G Moura; U Filho; F Franke; Annual Meeting of the American Society of Clinical Oncology 2010 Orlando) (41
Journal of Clinical Oncology Philadelphia v. 23, n. 16S , p. 751s, res. 8090, 2005Philadelphia 2005
Available at FMRAD - Fac. Medicina-Depto. Radiologia (INRAD 2861509 2005 )(GetIt)
- 0
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
inrad 2862663 2005
inrad 2483754 2008
browse_callnumber
display.do?gathStatTab=true&dscnt=0&callNumberBrowseField=browse_callnumber&tabRealType=browseshelf&mode=Basic&vid=USP&rfnGrp=1&rfnGrp=2&tab=usp_producao&dstmp=1722415671823&rfnGrpCounter=1&fctV=Federico%2C+M&fctV=Qualidade+De+Vida&callNumber=inrad+2861509+2005&fctN=facet_creator&fctN=facet_topic&vl(freeText0)=Cancer&ct=display&fn=search&indx=7&recIdxs=0&elementId=0
Previous
Home Page
RSS
Feed
Policies
Contact Us-
Implemented by:
Social Network Logos: 